US government increases pressure on Germany over drug pricing policies
Story essentials
US Government, German Federal Government
Germany, USA
June 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 16/19/2026, 8:21:01 PM
The US government has launched an investigation into whether Germany systematically underpays for innovative drugs. The dispute centers on the proposed 'GKV-Beitragsstabilisierungsgesetz' (GKV Contribution Stabilization Act). The US trade representative suggests this could lead to punitive tariffs on German goods.
Read next
Prioritized by shared people, places, and events.
S&P 500 performance outlook for 2026
The S&P 500 has risen by about 10% since the beginning of 2026. Some analysts are skeptical about maintaining this growth through the end of the year. Recent forecasts suggest potential losses by year-end.